Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
138 Cards in this Set
- Front
- Back
lowest drug concentration that prevents visable microbial growth after a 24 hr incubation |
MIC (minimum inhibitory concentration) |
|
level of MIC at which a bacterium is deemed either susceptible or resistant to an antibiotic (vary for diff classes) |
Breakpoint |
|
Who establishes breakpts? |
FDA+Clinical and Lab Standards Institute (CLSI) |
|
lowest drug concentration that reduces bacterial density by 99.9% in 24 hours |
MBC (minimum bactericidal concentration) |
|
effect of 2+ agents combined to produce a greater effect than the sum of their indv effects |
Synergy |
|
optimal sel, dosage, route of admin, and duration of antimicrobial treatment that results in the best clinical outcome |
Antimicrobial stewardship programs |
|
Common aspects of antimicrobial stewardship programs (4) |
1. oversee guideline development 2. restriction/pre-auth policy 3. automatic IV:PO med interchange 4. De-escelation or streamlining of therapy based on pt response and culture/susceptibility results |
|
chart that contains susceptibility patters of local bacterial isolates to antimicrobial agents at a single institution over a specific pd of time |
antibiogram |
|
have enhanced tissue penetration to bone, lung, brain |
lipophilic antimicrobials |
|
- on a susceptibility report indicates ___ |
drug was not tested against the bacteria (does NOT mean resistance!!) |
|
lipophilic agents (6) |
1. FQ 2. macrolides 3. rifampin 4. linezolid 5. tetracyclines 6. chloramphenicol |
|
These agents have hepatic metabolism and toxicity |
lipophilic agents |
|
These agents have renal metabolism and toxicity |
hydrophilic agents |
|
PO:IV ratio of lipophilic agents |
1:1 |
|
Active against atypicals (ITC) |
lipophilic agetns |
|
dosed more frequently to maximize time above MIC b/c r time-dept |
beta lactam |
|
concentration dept agents = dosed less freq + higher doses to maximize conc above MIC (3) |
aminoglycosides, FQs, daptomycin |
|
numerous studies have documented that extended/cont infusion of these can reduce length of stay, mortality, and costs, particulary when treating gram negative pathogens like Pseudomonas |
b-lactams |
|
T/F: bactericidal activity with mild infections (not immunocomp or endocarditis), does NOT imply improved pt outcomes |
TRUE |
|
1. DOC for perioperative px 2. how long is it initiated b4 surgery? |
1. first or second gen cephlosporins: cefazolin 2. w/i 1 hr (can be given rapidly just prior) |
|
1. When is vancomycin used for periop px? (2) 2. How long b4 surgery is vanc admin? why? |
1. a. MRSA concern b. b-lactam allergy 2. 2 hrs before incision (FQs are also given 2 hrs b4) - to avoid AE |
|
What can be used for colon or bowel surgeries? (3) |
(high risk anaerobic infection - use broader coverage:) 1. cefotetan 2. ertapenem 3. ceftriaxone + metronidazole |
|
1. meningitis triad symptoms 2. do ALL pts develop all 3 symptoms? |
1. a. severe HA b. nuchal rigidity (neck) c. altered mental status ...all due to meningue swelling 2. NO (others: chills, vomiting, photopobia) |
|
Most common cause of meningitis |
viral |
|
1. What is required for pts suspected of bacterial meningitis? 2. Should abx be dealyed until results come back from LP? |
1. lumbar puncture 2. NO!!! |
|
must be maximied to optimize CNS pentration
|
abx dosages |
|
T/F: with meningitis, likely pathogens and empiric abx sel depends on pt age |
True |
|
1. most likely meningitis pathogen in 2-50 yo 2. tx |
1. S. pneumo and N. meningitis 2. a. cefotaxime 2 gram q 4-6 hr b. ceftriazone 2 gram q 12 hr c. meropenem 2 g q 8 hr + vancomycin 30-45 mg/kg/day divided +/- dexametasone 0.15 mg/kg IV q6 hr x 2-4 days + ampicilliin 2g q4 hr (if <1 mo. or >50 yo, suspected Listeria) |
|
DOT for meningitis |
1-2 weeks |
|
1. most likely meningitis pathogen in >50 yo 2. tx |
1. S. penumo, N. meningitis, L. monocytogenes 2. vanc + ampicillin + ceftriaxone/cefotaxime |
|
What are options for meningitis in PCN allergy? |
chloramphenicol + vanc +/-Bactrim (for Listeria) |
|
What would be the CSF trend in meningitis? |
1. LOW glucose 2. high WBC 3. high protein |
|
most common childhood infection in US |
AOM (acute ititis media) |
|
What is otorrhea? |
middle ear effusion/fluid |
|
What is otalgia? |
ear pain |
|
what is the most common cause of AOM? |
viral |
|
Tx for AOM? |
1. pain: APAP or ibuprofen...topicals: benzocaine, procaine, lidocaine in children >5 yrs 2. Abx |
|
1. Who may be observed? 2. How long? |
1. NO otorrhea or severe symptoms: unilateral or bilateral and >2 yo 2. 2-3 days |
|
1. First line abx for AOM 2. tx duration |
1. in 2 div doses: a. amox 80-90 mg/kg/day b. Augmentin 90 mg/kg/day + 6.4 mg/kg/day clav 2. <2 yo: 10 days 2-5 yo: 7 days >5 yo: 5-7 days |
|
Alterv if PCN allergy for AOM |
cefdinir, cefuroxime, cefpodoxime, ceftriaxone |
|
Risk with high clavulaonate levels |
GI AE - best to use amox 600 mg/42.9 mg clav/5 ml (Augmentin ES 600) |
|
Option if pt cannot tolerate oral med due to GI AE? |
ceftriaxone 1-3 days (1 day for tx initial and 3 if tx failure) |
|
1. When do children recieve Prevnar? 2. ADULT vaccine with 23 serotypes? Who else should receive? |
1. 2, 4, 6, 12-15 mo. 2. Pneumovax: also give to children >2 yo who are immunocompromised |
|
When should children start receiving flu vaccine? |
>6 mo
|
|
Should Drs prescribe px abx for AOM? |
NOOO! |
|
fluid+infl in middle ear WITHOUT s/s acute inf |
otitis media WITH effusion (OME) |
|
rapid onset s/s infl + effusion in middle ear |
AOM - MUST be <2 day onset s/s |
|
What causes the majority of URTIs (common cold, flu, pharyngitis, sinusitis)? |
viruses |
|
1. When can oseltamivir or zanamavir be given for flu? 2. tx duration |
1. <48 hrs since symptom onset, RF for severe dx 2. x 5 days |
|
Possible bacterial pathogen causing pharyngitis |
S. pyogenes |
|
1. When can abx be given for pharyngitis? 3. tx 2. duration |
1. + culture for S. pyogenes 2. PCN, amoxicillin, 1/2 gen ceph (allergy: clarithro/azithro/clinda) 2. x 10 days (azithro x 5 days) |
|
Caused by rhinovirus, coronavirus, RSV |
common cold |
|
if bacterial, caused by S. pneumo, H flu, morexalla catarrhalis, staph anaerobes, gram neg rods |
sinusitis |
|
1. indications for sinusitis tx (4) 2. First line tx |
1. a. >1 wk symptoms
b. tooth/face pain c. nasal discharge/drainage d. congestion or severe/worsening symptom 2. Augmentin or doxy (x~7 days) |
|
LRTIs |
1. bronchitis 2. pneumonia 3. TB |
|
catogories bronchitis |
1. acute - viral cause, self-limiting (cough,sore throat low fever, HA, malaise, etc) **expect cough to last 2 weeks 2. chronic |
|
Tx for acute bacterial exacerbation of chronic brochintis |
inhaled anticholinergic (ipratropium/tiotropium) + oral corticosteriod x 2 weeks (including taper) |
|
Bacterial causes of CAP (3) |
1. Strep pneumo 2. H. flu 3. Morazella catarrhalis |
|
S/s CAP |
1. fever 2. prod cough + purulent sputum + chest pain 3. rales |
|
Gold standard for CAP dx |
chest x-ray |
|
Tx CAP: outpt vs inpt |
1. outpt: a. healthy/no abx in past 3 mo: macrolide OR doxycycline b. abx or comorb/immunosup OR inpt - nonICU: macrolide + b-lactam OR resp FQ = MGL 2. ICU: IV b-lactam + azithro/FQ allergy: FW + aztreonam |
|
What is CA-MRSA concern? |
add vanc/linezolid |
|
leading cause of infectious death in ICU |
HAP |
|
Most common causes of HAP <5 days after admit (early onset) |
same as CAP + more gram neg bacteria + atypicals (Legionella, Mycoplasma) |
|
Most common causes of HAP >5 days after admit (late onset) |
MRSA, pseudomonas |
|
Tx early onset HAP |
cetriatone, Unasyn, ertapenem, or Resp FQ |
|
Tx late onset HAP |
1. b-lactam with antipseudomonal coverage: cefepime,ceftrazidime, imipenem/meropenem/pip/tazo 2. gentamicin/tobramycin/amikacin/levoflox/cipro 3. MRSA RF: + vanc/linazolid |
|
HAP duration tx |
7-8 days (unless penudomonas or acinetobacteria or bacteremia: x 2 wks) |
|
Cuased by mycobacterium tuberulosis |
TB |
|
2 phases TB |
1. latent: NO symptoms 2. active - coughing, fever, purulent sputum |
|
diagnosied by TST (tuberculin skin test) = PPD (purified protein derivative test) |
LATENT TB |
|
When is area inspected after PPD? |
2-3 days later |
|
= positive PPD for all pts |
TST>15 mm |
|
Latent TB tx |
1. isoniazid 300 mg BWk x 9 mo OR 2. rifampin 400 mg QD x 4 mo. OR 3. INH + rifapentine qwk x 3 mo. |
|
Is rafampin + pyrazinamide regimen used?
|
NO - hepatotoxic |
|
Is active TB dx with a TST? |
NO - via sputum sample |
|
acid fast bacilli, anerobic, NON-spore |
Mycobacterium tuberculosis |
|
Is MTB lab stain conculsive for MTB? |
NO- non-sp - must use PCR or culture results |
|
Tx TB active dx |
4 drug regiment: RIPE: rifampin, INH, pyrazinamide, ethambutol |
|
When is the PRIME regimen used? |
= add moxifloxacin, use if MDR-TB is a concern |
|
1. How long is the initial tx phase for active TB? 2. tx cont phase |
1. x 2 mo. - until cultures come back, then narrow tx 2. a. if susceptible: INH + RIF x bWk for 18 more wks b. if resitant to INH: all others + moxi for 18 more weeks, etc if sint suseptable to INH: add FQ for 1 yr - 18 mo |
|
carries neuropathy risk, which can be reduced by pyridoxine intake = Vit B6 25-50 mg PO QD |
INH |
|
When if rifabutin used instead of rifampinI? |
if pt taking PI (CI) |
|
Must be taken on empty stomach (2) - 1 hr BEFORE, or 2 hrs POST meals |
1. INH |
|
causes increased LFTs, rash/prutitus, orange-red body secretions, flu-like syndrome |
rifampin |
|
BBW heaptitis |
INH |
|
AE: GI upset (2) |
1. INH 2. pyrazinamide |
|
AE: increased LFTs |
INH, rifampin |
|
Can cause DILE |
INH |
|
+ Coombs test |
1. Rifampin 2. INH |
|
risk hyperuricemia, gout |
pyrazinamide |
|
rsik optic neurits, must have routine vision tests |
ethambutol |
|
indicated for MDR-TB |
bedauiline - QT prolongation BBW!! |
|
Streptomycin can increase __ toxicity |
nephro |
|
most prevalent infection on the planet |
TB |
|
Treatment for TB should always include an adherence plan that emphasizes ___ |
DOT = directly observed therapy |
|
symptoms infective endocarditis (IE) |
fever + heart murmur |
|
Most common organisms causing IE |
1. Staph 2. Strep 3. Enterococcus |
|
How is IE dx? |
modified Duke criteria - includes echo |
|
emperic tx IE |
vanco + ceftriaxone |
|
Should extended interval dosing be used when treating endocarditis? |
NO!! |
|
What is the synergistic target peak and trough for gentamicin in IE |
1. peak: 3-4 mcg/ml 2. torugh <1 mcg/ml |
|
Who should recieve px abx before dental procedures to prevent IE? |
1. prosthetic heart valve 2. hx IE 3. heart transplant 4. congenital heart defects |
|
PX regiment for IE dental procedue |
1. amoxicillin 2 g PO 2. allergy: clinda 600 mg OR azithro/clarithro 500 mg |
|
Second most common cause inf mortality in ICUs |
intra-abdominal inf |
|
catogories intra-abdominal inf |
1. primary peritonitous (spontaneous) 2. secondary 3. tertiary peritonitis 4. biliary tract (cholecystitis and cholantitis) |
|
Who is most likely to develop primary SBP/primary peritonitous, tx |
liver dx pts - tx: ceftiraxone x 5-7 days |
|
Intra-abdominal inf caused by traumatic events (ulceration, ischemia, obstruction, surgery) |
secondary, tx: drain abscess |
|
infection of gallbladder |
cholecystitis - surgically managed |
|
primary skin and soft tissue infections |
cellulitis and impetigo |
|
infection that affects ALL layer of skin |
cellulitis |
|
tx non-purulent cellulitis |
b-lactam |
|
tx purulent celllulitis |
clinda/TMP/SMX/doxy |
|
What can be used to treat recurent SSTIs in pts with nasal MRSA colonization? |
intranasal mupirocin (Bactroban) BID x 5 days |
|
pus that extends into subQ tissue |
furuncle |
|
UTI most common |
cystitis: bladder and urethra (lower urinary tract) |
|
most severe UTI |
upper urinary tract: pyelonephritis (kidneys) |
|
Why are UTIs more common in women? |
shorter urethra (shorter route for organisms to travel) |
|
s/s UTI |
1.dysuria 2. urgency 3. freq 4. burning 5. suprapubic heaviness 6. hematuria + urinalysis with pyuria + baceriuria |
|
Is fever a common UTI symptom? |
NO |
|
When is fever a symptom of UTI? |
pylenonephritis - along with flank and abdominal pain, N/V, etc |
|
1. Who is always treated for UTI, even if asymp with negative urinalysis? 2. duration |
1. preganant women - Augmentin or oral ceph 2. x1 wk |
|
Can cause cartilage tox and arthropathies if used in pregancy |
quinolones
|
|
can cause hyperbilirubin + kernicterus in 3rd trimester |
bactrim |
|
urinary analgesis |
phenazopyridine |
|
AE phenazopyridine |
1. HA/dizziness 2. stomach cramps 3. red-orange coloring body fluids |
|
Azo, Urisat, Pyridium |
phenazopyridine |
|
What can be done to minimize GI upset with Azo? |
take w/ food + 8 oz water
|
|
Tx acute, uncomplicated cystitis |
nitrofurantoin x 5 days (second line: DS bactrim x 3 days) ...both: BID |
|
Difference b/t tx of complicated and uncomp UTI therapy |
DURATION - for complicated: 10-14 days |
|
Tx pylenonephritis |
FQ: cipro, levo ONLY |
|
symptoms include abdominal cramps, bloody, soft, or water stool, fever |
C diff inf |
|
causes of toxic megacolon |
C. diff (causing pseudomembrainous colitis) |
|
Are probiotics beneficial for c. diff tx? |
NO - only for px |
|
What should be AVOIDED with CDI |
antimotility agents (risk toxic megacolon) |
|
Tx C. diff: mild-mod |
metronidazole TID 500 mg x 10-14 days |
|
tx c. diff: severe of 3rd occurrence |
vanc x 10-14 days (with 3rd occurrence: use vanc TAPER) |
|
most common travel-related illness |
traveler's diarrhea |